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Abstract
Alcoholism is a chronic relapsing and remitting disorder, where relapse to drinking is
often triggered by an intense desire for alcohol (craving) and the consequent motiva‐
tion to obtain alcohol (seeking). Environmental stimuli (cues) associated with past alcohol
use are believed to strongly contribute to relapse, as exposure to these cues can trigger
intense feelings of craving and drive alcohol seeking. Over the past several decades, much
progress has been made in identifying the neurobiological correlates of alcohol seeking
and relapse. Much of this progress is owed to the development of animal models and
advanced techniques to manipulate neural activity. In this chapter, we describe some of
the most commonly used rodent models of alcohol intake and seeking as well as the
methods used to identify the neural structures and circuits involved in alcohol-mediat‐
ed behavior. Several of the most routinely identified brain structures in alcohol seeking
are also described.
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1. Introduction
Alcohol use disorders (AUDs) constitute a major global health concern. In 2013 alone, 5.9% of
all deaths worldwide were attributed to alcohol intake (WHO, 2015). This statistic combined
with the social, emotional, and other physical consequences of excessive alcohol use makes it is
difficult to deny the ongoing need for preclinical research. Of greatest interest is identifying the
treatments  to  promote and maintain abstinence in individuals  diagnosed with an AUD.
Remission, however, is often characterized by a chronic vulnerability to relapse, which is poorly
understood. In fact, estimates of long-term relapse rates following remission are as high as 60%,
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depending on the treatment sought [1]. Lack of information on the neurobiological antece‐
dents and psychological determinates of relapse makes AUDs all the more problematic to
address.
Further complicating our understanding of the persistent risk of relapse are the complex
interactions between internal processes and the external environment. Most noted are the
relationships that develop between environmental stimuli (cues), both contextual and discrete,
and the internal states produced by alcohol. Over the course of alcohol use, specific cues
become associated with the effects of alcohol through a Pavlovian learning process, whereby
an associative (alcohol-cue) relationship is formed. Once the relationship has been acquired,
these associative cues are able to autonomously produce psychological and physiological
states that are powerful enough to elicit behavior responses. These responses have been
suggested to play an important role in the development of AUDs and relapse.
Even after lengthy periods of abstinence, exposure to drug-associated cues can trigger intense
feelings of craving and drive drug seeking [2–5], leading to relapse to drug use. When
considering alcohol in particular, this lingering sensitivity to related cues is especially prob‐
lematic given the omnipresent nature of alcohol and alcohol-related cues in society. Therefore,
it is important that the neurobiology of this phenomenon be understood so that more effective
and durable treatments for alcoholism can be designed.
In the following sections, we describe common methodologies used to probe the neurobiology
underlying primary and conditioned ethanol reward. Specifically, these methodological
sections detail several commonly used animal models and tools to manipulate the brain. We
then discuss the neural substrates that have been identified in ethanol-seeking behavior using
these models and tools.
2. Animal models
To gain an understanding of the neurobiological mechanisms underlying AUDs, numerous
animal models have been developed. These models are designed to reflect various aspects of
alcoholism. The most widely used procedures assess ethanol reward and reinforcement and
include drinking, self-administration, and conditioned place preference (CPP). These animal
models share significant homology to certain elements of AUDs in humans, such as the
patterns of alcohol consumption, responses to alcohol-associated cues, and alcohol-seeking
behavior. Note that, in this review, the terms reward and reinforcement are distinguished from
one another. Although reward is used to refer to the appetitive nature of a stimulus as indicated
by the ability of environmental stimuli to elicit approach behavior, reinforcement will refer to
experimental contingencies that increase the likelihood of behavior(s) occurring [6, 7]. It should
be noted that no animal model could fully emulate all aspects of human alcoholism. However,
animal models allow for unparalleled access to the brain and thus provide a means to evaluate
neural mechanisms involved in the aspects of alcohol reward and dependence. These models
therefore represent invaluable preclinical tools for identifying potential biological correlates
of and treatments for AUDs.
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2.1. Drinking
For nearly a century, it has been known that rodents, like humans, will voluntarily consume
alcohol [8, 9]. For this reason, rodents have long been used in drinking procedures that involve
home-cage access to alcohol (ethanol). This represents the simplest way to gauge ethanol
reward, through consumption, which is done simply by providing rodents with a bottle and
measuring the amount they drink. Although alcohol is occasionally the only solution provided
in drinking studies, two-bottle choice procedures are more commonly used in rodents and
yield an additional measure of preference for alcohol. In a two-bottle choice drinking proce‐
dure, home-cage access to alcohol and another alcohol-free fluid (typically water) is provided
continuously or at temporally controlled intervals. Evidence of ethanol reward is then
indicated by the amount consumed and preference for the alcohol-containing solution over
the other available fluid. Manipulations that affect alcohol consumption and/or preference but
not water or total fluid intake are believed to have interfered with the rewarding properties of
ethanol [10].
Although these studies have high face validity (as humans voluntarily consume alcohol orally),
they are often limited by the fact that, like humans, rodents are sensitive to the aversive taste
of ethanol. At higher concentrations, the aversive taste of ethanol makes it difficult for rodents
to drink to the state of intoxication. Therefore, procedures requiring oral intake of ethanol may
require water deprivation, slow increases in ethanol concentration, and/or the addition of a
sweetener such as sucrose to the ethanol-containing solution to help rodents overcome the
aversive taste [11, 12]. For instance, modified sucrose fading techniques [13] are a common
strategy that has been used to achieve voluntary consumption of high concentration of ethanol
in rodents. With this technique, sweeteners such as sucrose or saccharin are initially added to
an ethanol solution then slowly faded out. However, this illustrates a pitfall of these proce‐
dures, which is that the underlying motivation for ethanol consumption is not always
understood. For example, rodents may freely consume ethanol for the sweetened taste or for
its caloric value. Therefore, it is not always evident that ethanol is being consumed in this
procedure for its postabsorptive pharmacological effects. Additionally, intervention-induced
decreases in alcohol intake in this procedure do not always indicate that a manipulation
decreased the ethanol reward. It is possible that a reduced intake may reflect an enhancement
of the pharmacological effects of ethanol, resulting in a leftward shift in the dose-response
curve, which translates to an increased effect of ethanol at lower amounts. Furthermore,
rodents tend to titrate their dose of ethanol consumption and often do not reach blood ethanol
concentrations (BECs) of intoxication unless induced to consume greater volumes via sucrose
fading or limited access to ethanol [14]. As a result, care must be taken when interpreting results
in drinking studies, as the underlying reasons for decreased intake may not always be
apparent.
2.2. Self-administration
In self-administration procedures, rodents must successfully perform an operant response
(e.g., lever press or nose poke) to receive a small volume of an ethanol solution [15]. With this
method, requisite responding is used to assess the reinforcing value of ethanol. A major
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advantage of self-administration procedures is that they allow for the assessment of ethanol
reinforcement at distinct phases. Methodological manipulations in these procedures allow for
the evaluation of the development of and enhancement in ethanol responding, including in
the absence of drug (extinction) and the reemergence of responding to various environmental
stimuli after responding has been extinguished (cue-, stress-, and ethanol-induced reinstate‐
ment). Thus, this procedure can be successfully used as a model aspect of alcohol seeking (rate
of responding or latency to bar press for alcohol). Also, self-administration studies can be used
to assess the animal’s motivation to receive ethanol by increasing the difficulty of the requisite
responding (a progressive ratio schedule, in which responding requirements are increased
after every the delivery of reinforcer) and thus evaluating the willingness of the animal to work
for an ethanol reinforcer [16]. As with humans, rodents will exert effort to obtain ethanol and
this effort or seeking behavior can be reduced by administration of therapeutic agents
indicated for the treatment of AUDs, such as naltrexone [17]. As such, reinstatement proce‐
dures have been shown to be highly useful for the preclinical evaluation of pharmacotherapies
aimed at reducing ethanol relapse in humans (reviewed in [18]).
In addition to the rate and pattern of responding, self-administration procedures also yield an
additional measure of amount of alcohol consumed. However, similar to drinking studies, the
aversive taste of ethanol may be difficult to overcome in self-administration procedures.
Therefore, liquid deprivation and fading strategies have also been used to establish operant
responding for and consumption of ethanol. This similarly compromises straightforward
interpretations of the underlying purpose for the behavior. Interpretation of studies using
operant oral paradigms may also be complicated because it is difficult to distinguish between
the phases of intake. As training procedures are necessary to establish ethanol self-adminis‐
tration and responding or intake serves as the primary dependent variable, it can be challeng‐
ing to separate acquisition and learning from seeking, for example.
2.3. Place conditioning
Another approach to modeling reward in rodents is the CPP procedure. With this Pavlovian
(classical) conditioning procedure, a distinct environmental stimulus [conditioned stimulus
(CS)] can acquire incentive salience after being paired with a motivationally significant
stimulus [unconditioned stimulus (US)]. Ultimately, the previously neutral stimulus (CS)
develops the ability to elicit a conditioned motivational response similar to the response
elicited by the US. This mimics the ability of cues or contexts associated with alcohol (e.g.,
alcohol containers, odors, advertisements, and drinking establishments) to elicit craving and
seeking for alcohol in humans with AUDs. In addition, drug-induced CPP can be established
in humans in a laboratory setting, further validating this model [19]. As such, the CPP
procedure is widely used to study the motivational properties of many abused drugs, and
given its numerous benefits, the popularity of this procedure continues to grow. In the last
decade alone, there has been a greater than two-fold increase in the total number of publica‐
tions reporting its use (Figure 1). Thus, this procedure is considered one of the most popular
models of drug reward [20, 21].
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Figure 1. Annual number of CPP studies published over the last 20 years. Values were obtained from PubMed using
the search term “CPP” OR “place preference” OR “place conditioning”. Adapted from Tzschentke [20, 21].
In a standard ethanol CPP procedure, a discrete cue [e.g., visual or tactile stimulus; referred
to as the positive CS (CS+)] presented in one spatial location is repeatedly paired with ethanol,
usually administered by the investigator (i.e., noncontingently). On alternating sessions, a
different stimulus not paired with ethanol [typically paired with saline, the negative CS (CS-)]
is presented in a location adjacent to where the CS+ was presented. During this acquisition
phase, an association develops between the CS+ and the subjective effects of ethanol (US). In
the subsequent drug-free expression phase, animals are given access to the entire conditioning
apparatus and thus to both cues (CS+ and CS-). When given the choice between the CS+ and
CS-, animals assess the memory formed in the acquisition phase and will generally approach
and maintain contact with (i.e., prefer) the CS+ when a US is rewarding. In other words, if an
animal spends a greater amount of time with the ethanol-paired stimulus (CS+) in relation to
the nondrug-paired stimulus (CS-), this is taken as an indication of the positive motivational
effects of alcohol. Conversely, a greater amount of time spent with the saline-paired stimulus
compared to the ethanol-paired stimulus would be considered conditioned place aversion
(CPA) and taken to indicate a negative motivational effect of ethanol. The ability of alcohol to
produce CPP or CPA depends on many factors, such as past history of ethanol exposure, route
of administration, injection timing, and dose (e.g., [22–26]). A result of conditioned reward or
aversion can vary by species and strain. Although conditioned ethanol responses have been
reported in some strains of rat (e.g., [27–29]), studies overall have shown conflicting results
ranging from lack of CPP [30] to CPA [31, 32]. However, ethanol CPP has been found in a wide
array of mouse strains [33] and thus has much utility as a model of ethanol reward in this
species.
Unlike self-administration, CPP does not require a lengthy training phase. In fact, in an inbred
st rain of mouse (DBA/2J) commonly used in ethanol CPP, a significant place preference can
be conditioned after only two ethanol-cue pairings [34–36]. Another advantage to this
procedure is that it does not involve oral intake of ethanol, which is required in drinking and
self-administration procedures. This is highly beneficial in cases where manipulations, such
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as pharmacology agents, reduce general consummatory behavior in addition to ethanol
reward or reinforcement. For example, erroneous conclusions may be made when a drug with
anorectic liability reduces the oral intake of ethanol. However, because CPP involves noncon‐
tingent ethanol administration, the effect of anorectic drugs on ethanol reward can be assessed
more accurately [35]. The place preference paradigm also permits for the evaluation of
manipulations on the various phases of learning an ethanol-paired cue that are often difficult
to isolate in other procedures, and an understanding of these various phases of learning is
important for understanding the progression of alcohol addiction. These phases include the
acquisition, conditioned expression, extinction, and reinstatement of the conditioned effects
of ethanol. Acquisition and conditioned expression of CPP are described in the paragraph
above. Extinction occurs following repeated exposures to the CS+ unpaired with the US
(ethanol), which results in a loss of conditioned responding as the animal learns that the CS+
and US are no longer associated and the CS+ loses its rewarding value. Reinstatement, the
phase most comparable to relapse in the human condition of addiction, is the reemergence of
ethanol-seeking behavior following extinction, usually elicited by a priming injection of a low
dose of ethanol (US), stress, or ethanol cues before being placed within the conditioning
apparatus. Specifically, when a manipulation disrupts the expression of ethanol CPP, this is
generally taken to indicate that it interfered with the conditioned rewarding effect of ethanol
or ethanol seeking. Indeed, because CPP can be used to gauge the conditioned rewarding or
motivational value of stimuli, it also serves as an effective method to measure cue-induced
ethanol-seeking behavior. On the other hand, manipulations that disrupt the development
(acquisition) of CPP are thought to impact either associative learning or the primary rewarding
effect of ethanol. To distinguish between these two possibilities, this procedure can also be
used to assess whether the manipulation also disrupts the acquisition of other associations
such as CPA induced by ethanol or other drugs (e.g., [34]). However, if a manipulation
specifically affects the extinction of CPP, it is thought to impair the formation of an inhibitory
memory, which relies on different neural structures than those required for the acquisition of
CPP. If a manipulation impairs the reinstatement of CPP, it is thought to either impair
mechanisms that allow for evaluation updating or reemergence of behavior, but manipulations
could also prevent access to the original acquisition memory and manipulations must be
assessed for specificity to reinstatement.
One disadvantage of the CPP procedure is that the drug is administered by the investigator
and therefore delivered noncontingently. Although this may be considered an advantage
given the control over the dose it provides, it reduces the face validity of this model. Unlike
humans, in this procedure, rodents do not consume alcohol of their own volition. Similarly,
humans do not take alcohol via intraperitoneal injections, as is used in this animal model.
Moreover, this procedure does not typically involve an escalation in intake, as is usually
observed in humans. Comparable to self-administration procedures, manipulations that affect
locomotor activity may also nonspecifically impact CPP expression. It has been previously
demonstrated that increases in activity may disrupt ethanol CPP expression, thereby obscuring
its detection [37]. Hence, results obtained by manipulations that increased or decreased
preference test activity must be cautiously interpreted. Despite these drawbacks, this model
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presents a rapid and efficient method to evaluate the primary and conditioned motivational
effects of ethanol in rodents.
2.4. Summary
In summary, animal models have been used extensively in alcohol research, with several
models designed to study the various aspects of ethanol-mediated behavior. The most
standard used procedures to model ethanol seeking are self-administration and CPP. Al‐
though it should be noted that no one procedure is able to mimic all features of human alcohol
use, these models allow for the investigation of the underlying neural mechanisms involved
in distinct alcohol-related behaviors. Furthermore, the paradigms described here do not
encompass all models of AUDs available. Additional models include operant runway models,
vapor chamber exposure, intracranial self-stimulation, and locomotor sensitization. In the
following sections, several commonly used techniques to probe the neural structures and
circuits involved in rodent behavior and their application to animal models of ethanol seeking
are described.
3. Tools to manipulate neural structures
Many techniques have been developed to evaluate distinct brain structures. These methods
allow for the direct manipulation of a defined brain area to manipulate their activity during
behavior. Thus, they require intracranial access typically gained through stereotaxic surgery.
Of these methods, the most widely used are lesions and microinjection. However, more
modern tools have been developed that harness the capabilities of viral gene transfer to more
precisely control cells and circuits. Each of these techniques, classic and contemporary,
possesses inherent benefits and drawbacks that are discussed in detail below and summarized
in Table 1.
3.1. Classical tools
3.1.1. Lesions
A classical method used to study brain function involves the removal or destruction of neural
tissue. With this method, experimental lesions are made to defined brain structures through
manual, chemical, or electrical means and can also be neurotransmitter specific. Popular
neurotransmitter-specific lesioning agents include 6-hydroxydopamine (dopaminergic and
noradrenergic neurons), 5,7-dihydroxytryptamine (serotonergic neurons), ibotenic acid [N-
methyl-D-aspartate (NMDA) receptor-containing neurons], kainic acid (kainate receptor-
containing neurons), and many others. Behavior is then examined in the absence of this tissue,
thus providing insight into the involvement of the lesioned structure. Histology, such as simple
cresyl violet stains or for markers of neuronal damage, is performed on neural tissue after
behavior to confirm the location of damage. One issue that arises is the propensity for other
brain structures to compensate for the damaged region. This may severely compromise the
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interpretation of results obtained from studies using a lesion procedure. Another issue is the
difficulty encountered when using lesions to assess the effects at distinct phases of a behavior,
as lesions cause irreversible damage to the region. Thus, with many animal models, it is
difficult to determine whether ablation of a structure impacted the development (acquisition),
performance (expression), extinction, or reinstatement of behavior. To affect a distinct phase
of behavior, lesions can be made at specific times in the model. However, phase-specific lesions
can unintentionally alter later behavior and can even impair the memory of earlier phases.
Criteria Classical tools Contemporary tools
Lesion Microinjection Tracing Optogenetic Chemogenetic
Spatial
resolution
1 Depends on
lesion type
1 Spread
difficult to
determine
2 Labeled
spread;
targeted to
cells
2 Labeled spread;
targeted to
cells
2 Labeled spread;
targeted to
cells
Temporal
resolution
0 Permanent 1 Minutes to
hours
depending on
drug
0 Permanent 2 Milliseconds 1 Minutes to hours
depending on
actuator
Non
invasive
1 Single i.c.
entry but
involves
intentional
tissue damage
0 Permanent
hardware,
repeated i.c.
access
1 Single i.c.
entry, but
tracers may
be toxic
0 Permanent
hardware,
repeated i.c.
access
2 Single i.c.
entry,
activation by
peripheral
injection
Cell
specificity
0 Marginally
possible with
chemical
lesions
0 Receptors
targeted
across cell
types
1 Increased
with viral
tracers and
transgenic
strains
2 Using
transgenic
strains and
viral
promoters
2 Using
transgenic
strains and
viral
promoters
Minimal
need for
specialized
equipment
0 Current-
generating
device and
electrodes for
electrolytic
0 Surgical
stainless steel
cannula,
injectors
custom gauge
and length
2 Requires
micro
injectors only
0 Cannula
and fiber
optics of
custom length,
multichannel
light source
2 Requires
microinjectors
only
Circuit
specificity
0 Indirect with
disconnection
procedure
0 Indirect with
disconnection
procedure
1 Labeling of
defined
projections
2 With axonal
light excitation
2 With i.c.
actuator infusion
or anterograde/retro
grade viruses
Bidirectional
Modulation
Ability
0 Inactivation
only
2 Inhibition and
activation depend
on drug
n/a 2 Depends on
opsins and
wavelengths
2 Depends on
receptors and
actuators
0, low; 1, moderate; 2, high; i.c., intracranial.
Table 1. Comparison of commonly used classical and contemporary tools in behavioral neuroscience.
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3.1.2. Intracranial microinjections
The local administration of pharmacological agents into discrete brain targets is another
strategy to control neural activity. This technique typically requires permanent surgical
placement of guide cannula to allow for later access to otherwise inaccessible brain structures
while animals are awake and behaving. Small volumes of drug solutions are then administered
directly into the brain by threading a smaller gauge injector through the guide cannula. These
solutions typically contain drugs that bind to distinct membrane proteins (receptors) expressed
within the target brain region to enhance or inhibit local cellular activity during behavior.
Similar to lesions, histology is performed afterwards to verify the site of microinjection. This
procedure has several major advantages compared to lesions, most of which relate to its ability
to produce more temporally specific effects. Unlike lesions, the effects of most pharmacological
antagonists and agonists are temporary and can therefore be more precisely controlled and
administered during distinct phases of behavioral procedures. This allows for more straight‐
forward interpretation of the effects of this manipulation on behavior. Additionally, this
technique can provide insight into the neurochemical signals involved, as agents selective for
distinct receptor types can be infused. To a lesser extent than lesions, microinjections also
produce damage resulting in reactive gliosis from cannula installation and injector placement.
Finally, it is difficult to ascertain the exact extent of diffusion of the administered solution. As
diffusion may depend on a variety of factors, such as the volume injected and the nature of
the solution (polarity, hydrophobicity), it is difficult to predict. Thus, it is not always clear that
the site of infusion is the region directing the observed behavior. For this reason, it is often
necessary to include additional groups that receive drug injections in locations proximal to the
target structure.
3.2. Contemporary tools
In recent years, there has been a rapid emergence of novel tools engineered to control neuronal
activity. Of benefit to these tools have been the advancements in recombinant viruses that are
capable of gene transfer in the central nervous system (CNS). For example, viruses with low
immunogenicity and cytotoxicity such as adeno-associated virus (AAV) can be delivered
directly into the brain to safely and efficiently express recombinant genes [38]. This provides
a means to site-specifically express proteins in the CNS that can be used to modulate the activity
of cells in target brain tissue. Optogenetics and chemogenetics represent the two most widely
used contemporary tools in behavioral neuroscience, as they can be applied in vivo to modulate
neural activity in awake behaving mice and rats. As with the classical tools described above,
these modern methods have inherent advantages and disadvantages (Table 1), which are
detailed below.
3.2.1. Optogenetics
In this technique, neurons are genetically modified through intracranial injection of a viral
vector to express photosensitive proteins. The most commonly used photosensitive receptors
are channelrhodopsin (ChR; excitatory ion channel), halorhodopsin (NpHR; inhibitory ion
pump), and archaerhodopsin (ArchT; inhibitory proton pump; reviewed in [39]). These light-
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gated proteins are activated by targeted illumination, causing rapid (millisecond timescale)
depolarization or hyperpolarization of neurons (reviewed in [40]). By evoking or inhibiting
spike activity with this light-protein interaction, the activity of distinct brain regions and cell
types can be experimentally controlled, including during the performance of behavioral tasks
[39]. Because these engineered opsins can be controlled by different light wavelengths, neural
activity and behavior can be modulated bidirectionally (i.e., multiplexed), offering a major
advantage to this technique. Moreover, the high temporal resolution afforded by this tool
makes it ideal to examine the discrete phases of behavior. However, a major issue posed by
optogenetics is the possibility of desensitization of the opsin, which can occur within seconds
of photoactivation [41]. Thus, this is especially problematic for studies that require inhibition
or activation of longer durations, such as is required in certain behavioral tasks that occur on
the order of minutes. Repeated stimulation leading to the desensitization of the opsin may
even produce opposing results. This is especially problematic in the case of the excitatory opsin
ChR, as the desensitization of this receptor and repeated stimulation of the cell may result in
a net inhibition, the opposite effect of what is initially intended. The extent of viral diffusion
and resulting protein expression is easily measurable with this technique, as most viral
constructs contain a fluorescent tag. However, similar to microinjections, implantable
hardware is necessary to allow for intracranial insertion of fiber-optic probes. This technique
also requires specialized equipment such as fiber-optic probes and programmable light
sources, which can be costly. Tethering the animal to the external light source is also necessary,
which may restrict the range of apparatuses that can be used and behaviors that can be assessed
(although for recent developments in wireless technologies; see [42–46]). Recently, questions
regarding the effect of illumination in brain structures have arisen, specifically in regards its
thermal effects on neural tissue. It has been suggested that focal illumination, especially when
intense and prolonged, can result in phototoxicity, heat-induced cell damage, and oxidative
stress that independently alters cellular activity [47]. Even more problematic is evidence
indicating that heat alone can increase neuronal firing rates [48]. In fact, even at commonly
used intensities, the thermal effect of illumination is sufficient to increase cell firing rates [49].
Overall, optogenetics provides a unique tool to control neuronal activity with high
spatiotemporal resolution. However, the required implantable hardware, specialized
equipment, tethering, risk of desensitization, and light induction may render this tool less than
ideal given the experimental question and design.
3.2.2. Chemogenetics
This relatively new technique involves the engineering of G protein-coupled receptors
(GPCRs) to interact exclusively with small molecules that were otherwise unrecognized by the
GPCR [50]. The most common of these mutated GPCRs are designer receptors exclusively
activated by designer drugs (DREADDs) [51]. The engineered GPCRs possess no detectible
constitutive activity and are robustly activated at nanomolar concentrations of otherwise
pharmacologically inert compounds. The first established DREADDs were based on excitatory
Gq-coupled and inhibitory Gi-coupled human muscarinic receptors M3 (hM3Dq) and M4
(hM4Di), respectively [51–53]. Receptors hM3Dq and hM4Di possess no affinity for the
endogenous ligand acetylcholine and are robustly activated by the drug clozapine-N-oxide
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(CNO), a pharmacologically inert metabolite of clozapine, which is highly bioavailable and
produces no pharmacological effect in rodents [51, 54]. Since their inception, other DREADDs
have been engineered, which include a Gs-coupled muscarinic-based (rM3Ds) receptor and
Gi-coupled KOR-based DREADD (KORD) [55–57]. Notably, the development of KORD with
actuator salvinorin B allows for the bidirectional control of behavior when used in combination
with hM3Dq receptors and CNO [57].
Comparable to optogenetics, DREADDs can be ectopically expressed in the CNS by focal
infusion of a vector encoding for these receptors. A major advantage of chemogenetics over
optogenetics, however, is the lack of required specialized equipment and need for permanently
implanted hardware. In fact, DREADDs require just one initial intracranial entry to infuse the
viral vector carrying the DREADD-encoding gene. The receptors can then be activated by a
relatively noninvasive peripheral injection of an actuator. This is highly advantageous when
performing sensitive behavioral procedures that are affected by excessive handling (e.g., CPP
and self-administration) [58]. Similar to optogenetics, a more precise detection of viral spread
and DREADD expression are possible with this technique, as they are designed to encode for
DREADDs as well as a fluorescent marker.
Unlike optogenetics, DREADDs signal through canonical G-protein pathways. Once activated,
the duration of the inhibition or activation produced by the DREADD can be long lasting. The
duration of effect is also determined by the half-life of actuators, which may remain in central
tissue and activate DREADDs for minutes to hours. In some cases, this low temporal resolution
may serve as a major shortcoming of this technique. However, a protracted effect is often highly
valued in studies where behavioral tasks are of longer duration and long-lasting effects of
manipulations are desired. Another issue is that the presence of the receptor does not always
indicate that it is a functionality. Additional measures may be necessary to demonstrate the
function of these receptors in target tissue. Although it is theoretically possible, no studies have
reported DREADD desensitization. However, this presents another reason for including some
form of functional confirmation of DREADD effects.
In summary, DREADDs are a useful technique to control neuronal signaling in vivo. Consid‐
ering the sensitivity and duration of many behavioral tasks, the noninvasive nature of
DREADD activation (i.e., peripheral drug injection) and longer time course of inhibition/
activation make chemogenetic strategies highly desirable in behavioral research.
3.3. Summary
The above-described tools provide a means through which to target and manipulate brain
regions. These tools offer variable degrees of selectivity, with contemporary techniques
typically being associated with higher precision in terms of spatial and neuronal targeting. The
tools mentioned above do not encapsulate all available methods of discovering the neurobi‐
ology behind behaviors. Other commonly used methods not described in this chapter are
intracranial electrical or self-stimulation, intracranial microdialysis, electrophysiology,
immunohistochemistry (IHC), genetic knockout rodents, and many others that similarly assess
the importance of a brain region and specific neurotransmitter systems to behavior.
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4. Tools to manipulate specific neural pathways
Historically, the direct manipulation of neural circuits has been a challenging task, with much
of the difficulty due to limited methodologies. In the past, many of the tools used possessed
relatively low selectivity and provided indirect manipulation. Several strategies, however,
have been designed using both classical and contemporary tools to probe the neural circuitry
underlying behavior. This section describes several commonly used strategies and includes a
discussion of their merits and weaknesses.
4.1. Classical tools
Historically, disconnection procedures involving lesions and pharmacological microinjections
have been used to evaluate neural circuitry. This strategy involves the disruption of two
directly connected brain regions to assess whether their interaction is involved in behavior
(e.g., [59–62]). Typically, a unilateral lesion or inactivating microinjection [e.g., γ-aminobutyric
acid (GABA) agonists or channel blocker] is made in source regions and another lesion or
microinjection is made in the contralateral hemisphere of its terminal target. Thus, if a behavior
is dependent on a source-target interchange, then their contralateral disconnection should be
more disruptive to behavior than ipsilateral disconnection or unilateral manipulation of each
region individually. However, a major weakness of this strategy is the indirect nature of the
manipulation on the circuit. Indeed, the imprecision of this method has at times been proven
problematic resulting in significant reductions in behavior with ipsilateral and unilateral
manipulations alone (e.g., [60]). This is likely due to the inability of this technique to directly
target distinct yet intermixed populations of target-projecting neurons within source regions.
Instead, each region is broadly manipulated leading to the inhibition of their overall activity
and output throughout the brain.
To help visualize and identify the circuit, neuronal tracing has sometimes been used in
conjunction with these classical tools. In these studies, tracing agents are injected into the brain
to label neurons in a manner that is retrograde (axon terminal back to the soma), anterograde
(soma to axon terminal), or transsynaptic (to adjacent neurons retrogradely or anterogradely).
In studies of behavior, circuit involvement is inferred by colabeling of neuronal activity
markers such as c-Fos with the tracer through IHC (e.g., [63]). Cells that are immunopositive
for both the tracer and activity marker are then used to identify afferent or efferent projection
neurons that were activated during behavior. When used in tandem with disconnection
procedures, this provides a means to visually assess the impact of disconnection on circuit
activity (e.g., [62]). Although these procedures help to label neurons within the circuit and
gauge their activity, they still fall short of allowing isolated modulation of the circuit. Overall,
this remains a major weakness of classical techniques, as results only offer an indirect measure
of neural circuit involvement in behavior.
4.2. Contemporary tools
Optogenetic and chemogenetic strategies have provided a refined and more selective means
to directly manipulate neural circuits. This is principally due to viral transduction, as proteins
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(opsins and DREADDs) are trafficked downstream from soma to axon terminals (anterograde)
and therefore expressed on presynaptic boutons as well as to cell bodies [64]. In the case of
optogenetics, illumination can then be targeted to axon terminals, which results in the
depolarization or hyperpolarization of the neuron. This strategy has been successfully
implemented in many behavior studies (reviewed in [64]). However, a concern that arises
when using this method is the possibility of antidromic stimulation of the cell. The stimulation
of terminals may result in the back-propagation of an action potential that activates the neuron
and its collateral inputs to other regions outside the circuit of interest. Therefore, with this
strategy, there is a potential for the activation of multiple circuits, which diminishes the
selectivity of the manipulation.
Several chemogenetic-based strategies have been used to modulate neural circuit activity.
First, a functional disconnection procedure methodologically similar to that used with lesions
or microinjections has been reported by Mahler et al. [65]. In this study, hM4Di receptors were
unilaterally expressed in ventral tegmental area (VTA) dopamine (DA) cells and contralater‐
ally in rostral ventral pallidum (RVP) cells. The contralateral disconnection of RVP-VTA DA
reduced cued reinstatement of cocaine seeking relative to both unilateral RVP inhibition and
unilateral VTA DA inhibition. Despite these positive results, it is unclear whether the simul‐
taneous inhibition of RVP and VTA DA, regardless of hemisphere, would have been sufficient
to produce a similar effect. Thus, with this technique, it is important to include ipsilateral as
well as unilateral controls. In summary, the lack of precision and necessary inclusion of
numerous controls renders this a less desirable strategy for the targeted modulation of neural
circuits.
Another DREADD-based method that has been used involves the intracranial injection of
CNO. The principle behind this strategy is similar to that of the optogenetic circuit-selective
method outlined above. Here, like illumination, CNO is targeted to the terminal region of
DREADD-expressing cells [65, 66]. The focal infusion of CNO therefore serves to activate/
inhibit DREADD-expressing cells and/or presynaptic neurotransmitter release from
DREADD-expressing nerve terminals [66]. In this manner, the activity of defined neural
circuits can be more precisely controlled. However, given that this strategy requires intracra‐
nial microinjections, it also carries with it the disadvantage of requiring permanently indwel‐
ling hardware (i.e., guide cannula and obturators), repeated intracranial entries, and a resulting
increased risk of tissue damage.
An alternative approach to this involves the intersection of multiple viruses that are injected
into serially connected nuclei. Typically, a retrograde virus encoding for cre recombinase is
injected in a target region and a cre-inducible virus encoding for DREADD is injected into the
source region. In this manner, the activity of a specific source’s inputs to the target region (i.e.,
projection neurons) can be controlled by the systemic injection of CNO. This approach has
been successfully implemented using canine adenovirus (CAV-2) to retrogradely infect source
region cells and selectively express DREADDs in a specific neural projection [67–69]. Notably,
this strategy provides an ideal way to control circuits, especially during behavior. Not only
does this method provide a high degree of selectivity, it does not require implantable hardware
and can be robustly activated by a simple peripheral injection of an actuator. Theoretically, it
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is possible for axon collaterals from source region cells to express DREADDs, which given the
systemic nature of DREADD activation may lead to activity in sites outside the circuit. Hence,
studies using this method should be careful to address this potential caveat.
4.3. Summary
Overall, several techniques involving classical and contemporary tools have been used to
manipulate defined neural circuits. On one hand, classical tools provide indirect manipulation
and generally require the use of multiple controls to carefully and appropriately interpret
results derived using these strategies. Conversely, contemporary tools involving viral-
mediated gene transfer confer greater circuit selectivity and have been successfully used to
manipulate serial projections form source to target region.
5. Neural structures involved in ethanol-seeking behavior
In the following sections, several neural structures and circuits involved in ethanol-seeking
behavior are discussed. Building off of earlier sections, the studies that are described below
involved several different animal models and tools to identify the underlying neurobiology of
ethanol seeking. Specifically, this chapter will focus on the neural structures involved in
ethanol self-administration and CPP, as these models specifically assess ethanol-seeking
behavior. A proposed circuit of the key neural structures implicated in cue-induced ethanol
seeking as indexed by self-administration and CPP procedures is included in Figure 2.
5.1. Findings from ethanol self-administration studies
Studies using ethanol self-administration procedures to evaluate the neural mechanisms
underlying ethanol seeking have by and large employed intracranial microinfusions. Most of
the neural regions that have been evaluated in self-administration studies are part of the
mesocorticolimbic system [70] and are typically situated downstream of the VTA. As with
many drugs of abuse, acutely administered ethanol excites DA neurons within the VTA
through direct and indirect mechanisms [71–74]. Furthermore, the VTA is robustly activated
by ethanol-associated cue exposure [75]. Downstream, the nucleus accumbens (NAc) and
amygdala receive dopaminergic input from the VTA [76] and considerable evidence suggests
that this dopaminergic input to each region underlies associative learning and motivated
behavior [77–81]. As such, NAc and amygdala are two of the most well-characterized struc‐
tures in terms of their involvement in ethanol seeking and several of these studies are described
below.
The NAc has been routinely implicated in the drug-seeking behavior [82, 83]. Many studies
have found a differential involvement of core and shell subdivisions in drug seeking depend‐
ing on the drug of abuse, phase of self-administration, and nature of the procedure and/or
stimuli used [84–86]. As with other drugs of abuse, the NAc core and shell have been shown
to be differentially involved in cue-induced ethanol seeking. For example, ethanol self-
administration studies have shown that transient inactivation of the NAc core but not shell
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reduces cue-induced reinstatement [87] and context-induced renewal [88] of ethanol seeking.
Other studies, however, have demonstrated that NAc shell modulates the expression of cue-
induced ethanol seeking [89] and that blockade of DA D1 receptors in the NAc shell but not
core reduces the spontaneous recovery of ethanol-seeking behavior following prolonged
abstinence [90]. In addition, DA D1 receptor antagonism in NAc core and shell has been
reported to block context-induced renewal of extinguished ethanol seeking [91]. These studies
vary in their findings of core versus shell involvement in ethanol seeking, likely indicating that
the role of NAc subdivisions varies by different phases of self-administration (e.g., acquisition,
expression, and reinstatement) and by the use of cues or context. However, this literature
overall supports a role for the NAc in general ethanol-seeking behavior and suggests that DA
input may underlie its involvement.
The amygdala has also been strongly implicated in drug-seeking behavior, specifically the
basolateral amygdala (BLA) and central nucleus of the amygdala (CeA) subdivisions as well
as the bed nucleus of the stria terminalis (BNST) of the extended amygdala [92–94]. In ethanol
Figure 2. Diagram of the neural circuitry involved in ethanol CPP. Previous studies have demonstrated the involve‐
ment of cortex (ACC), amygdala (BLA/CeA), striatum (NAc), and midbrain (VTA) in ethanol CPP. The present work
now demonstrates the involvement of the dorsal and ventral BNST (dBNST and vBNST, respectively) and a direct
BNST-VTA circuit. Each of these regions receives dopaminergic input from the VTA (indicated by blue arrows) and is
part of a broader mesocorticolimbic dopamine system that underlies reward and motivation. Some of the neurochemi‐
cal signals underlying the involvement of each region in ethanol CPP have also been identified. +, excitatory; -, inhibi‐
tory; blue circles, dopamine cells; green rectangles, glutamate cells; red squares, GABA cells; black boxes, unknown
neurochemical signal; green arrows, glutamate projections; μ, μ-opioid receptors; B, GABAB receptor; D1, dopamine
D1-like receptor; D2, dopamine D2-like receptor; iGluR, ionotropic glutamate receptors, NMDA, iGluR subtype.
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self-administration studies, the inactivation of the BLA has been shown to reduce context-
induced renewal of previously extinguished ethanol seeking [95]. The involvement of the BLA
in ethanol seeking may involve a glutamatergic mechanism, as intra-BLA ionotropic glutamate
receptor antagonism reduced the expression of ethanol seeking elicited by a discrete cue and
invigorated by an ethanol-associated context [96]. Notably, the excitatory transmission from
the amygdala to the NAc is believed to underlie reward seeking and suggests that an amyg‐
dala-NAc circuit may be involved in the expression of reward-seeking behavior. For example,
the optical stimulation of BLA glutamate to NAc has been shown to be reinforcing, as mice
worked to earn additional stimulation of BLA-NAc synaptic inputs [97]. Conversely, the
inhibition of BLA-NAc inputs reduced cue-induced responding for sucrose [97]. In addition,
pharmacological disconnection has revealed that an amygdala-NAc interaction underlies a
stimulus-controlled expression or maintenance of cocaine seeking [59].
The CeA and BNST have generally been implicated in stress-induced ethanol-seeking rein‐
statement but may also play a role in cue-induced ethanol reinstatement. For instance, intra-
CeA but not intra-BLA infusion of mifepristone, a glucocorticoid receptor antagonist, has been
reported to suppress reinstated ethanol seeking induced by the pharmacological stressor
yohimbine [98]. Activation of group II metabotropic glutamate receptors blocks stress- and
cue-induced reinstatement of ethanol seeking presumably through CeA and BNST actions [99].
Lastly, additional regions that have been implicated in ethanol seeking using self-administra‐
tion procedures include the dorsomedial striatum [100, 101], medial prefrontal cortex (mPFC)
[75], prelimbic cortex, and VTA [102]. Importantly, the VTA, which is the chief source of DA
input to NAc, amygdala, and cortical regions, has been shown to be explicitly involved in
context- and cue-induced ethanol seeking [103–105]. Overall, self-administration studies have
been important in identifying several key neural substrates involved in ethanol-seeking
behavior. Several of these structures have also been implicated in cue-induced ethanol seeking
through ethanol-induced CPP procedures and thus are discussed in the next section.
5.2. Findings from ethanol CPP studies
Studies on the neural mechanism of ethanol CPP can be grouped into several categories that
include acquisition, expression, extinction, and reinstatement. Acquisition studies are those
that assess the development of ethanol place preference. These typically include procedures
where manipulations occurred during the conditioning or training phase, where animals learn
to associate contextual cues with ethanol reward. Conversely, expression studies involve
manipulations that occur after the conditioning phase and before preference testing. Expres‐
sion studies, in particular, are useful in assessing ethanol-seeking behavior and conditioned
reward. Below, findings from each of these types of ethanol CPP studies are discussed. Of note,
relatively few laboratories study the primary and conditioned rewarding properties of ethanol
using a CPP procedure. This is partly due to the difficult and unreliable nature of ethanol place
conditioning in rats [21, 106] and the relatively weak ethanol CPP obtained with commonly
used inbred mouse strains, such as C57BL/6J [107, 108]. In view of this, many of the studies
described below have used male DBA/2J mice. This inbred strain will rapidly and reliably
develop and ethanol CPP, even with a minimal amount of conditioning sessions [34, 36, 108].
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In this section, we provide an overview of studies that have directly examined the neural areas
underlying the acquisition and expression of ethanol place preference.
5.2.1. Acquisition
As with self-administration studies, the NAc and amygdala are the two most evaluated regions
in terms of their involvement in ethanol CPP acquisition. Previously, the involvement of the
NAc in ethanol place preference acquisition has been investigated. In one study, bilateral
electrolytic lesions of the NAc before CPP training disrupted the acquisition of CPP [109]. In
a later study, bilateral NAc infusions of the D1-like receptor antagonist SCH-23390 disrupted
the development of ethanol CPP [110]. This finding is similar to a finding reported in rats
showing that nonselective DA antagonism prevented CPP induced by intracerebroventricular
(icv) infusions of ethanol [111]. Combined, these studies indicate that the NAc is necessary for
establishing associative relationships between ethanol reward and environmental cues likely
through a DA D1-like receptor-dependent mechanism. Other work has looked at the role of
the amygdala in ethanol CPP acquisition [109]. Using electrolytic lesions, the amygdala was
ablated bilaterally before CPP training. Amygdala lesions disrupted acquisition (and/or
expression) of ethanol place preference, suggesting that this region is also involved in ethanol
cue learning.
Together, these findings demonstrate that these structures downstream the VTA are necessary
for the development of ethanol CPP. Moreover, NAc involvement in ethanol CPP is directly
attributed to dopaminergic innervation, as activity at D1-like receptors in this region is
necessary for acquisition. One consideration of these results is that acquisition studies
involving microinjections can be problematic, as the additional handling required to focally
administer a drug can interfere with ethanol CPP [110]. Although they do not require added
handling prior, lesions are also problematic when administered preconditioning, as it unclear
whether they affected the acquisition or expression phase.
5.2.2. Expression
Over the last decade, studies have investigated the involvement of several brain areas in
ethanol place preference expression. These include the VTA, NAc, amygdala, and anterior
cingulate cortex (ACC). Each of these structures is thought to be involved in reward and
motivation partly through DA mechanisms, and as such, each is part of a broader mesocorti‐
colimbic DA system.
Although VTA DA cells are initially activated by rewarding stimuli, this activation diminishes
over time with repeated reward exposures and subsequent learning [112]. Eventually, DA cells
are no longer activated by the reward itself and instead become robustly activated by envi‐
ronmental stimuli that have become associated with the reward and predict its delivery [113,
114]. Thus, the involvement of this conditioned DA response in ethanol CPP expression can
be supported by studies focusing on the VTA or downstream sites as are described below.
One pharmacological microinjection study separately infused the nonselective opioid receptor
antagonist methylnaloxonium and the GABAB receptor agonist baclofen into the VTA to assess
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the participation of the VTA in ethanol CPP expression. Methylnaloxonium decreased the
magnitude of ethanol CPP, whereas baclofen blocked preference expression entirely. These
findings suggested that the VTA activity is necessary for the expression of ethanol place
preference. Moreover, GABAergic and opioidergic activity appear to underlie the involvement
of the VTA in ethanol CPP expression, presumably through the local modulation of DA cell
activity.
Although involvement of the NAc in ethanol place preference acquisition is clear, its involve‐
ment in expression is more complicated. In early work, an intra-NAc infusion of methylna‐
loxonium failed to impact ethanol preference expression, suggesting a lack of NAc opioid
receptor involvement in the conditioned ethanol reward [115]. A later study directed bilateral
electrolytic lesions at the NAc after ethanol CPP conditioning and before testing to isolate the
involvement of this structure in expression [109]. Overall, lesions made at this time point did
not affect ethanol place preference, suggesting that the NAc may not be critical in ethanol CPP
expression.
However, additional pharmacological procedures have shown a more specific role for the NAc
in CPP expression. In one study, intra-NAc antagonism of D1- and D2-like receptors prevented
the expression of CPP induced by icv ethanol [111]. In another study, NAc DA (D1- and D2-
like) and glutamate (NMDA) receptors were blocked during the CPP expression test using
either flupenthixol or AP-5, respectively [116]. Although DA receptor antagonism did not
affect ethanol place preference, NMDA receptor antagonism reduced it, suggesting that the
involvement of the NAc in expression is specific to activity at NMDA receptors. This effect
was reproduced in another study using only unilaterally administered AP5, further indicating
the importance of NAc NMDA receptor involvement in ethanol place preference expression
[60]. Notably, this study was designed to examine glutamate input to NAc from amygdala.
Although findings appeared to demonstrate that amygdala disconnection from NAc blocked
ethanol CPP expression, reduced CPP in mice unilaterally infused with AP5 in NAc prevented
this interpretation. Overall, these findings have established a role for NAc NMDA, but not DA
receptors, in ethanol place preference expression and suggest that glutamatergic input from
amygdala may also be involved. Although DA input from VTA to NAc is a hypothesized
mechanism underlying drug seeking, these results suggest that it does not underlie ethanol
seeking, at least as indexed by CPP. Finally, these studies serve to demonstrate that manipu‐
lations more selective than global inactivation or deletion of a structure may be necessary to
appropriately gauge that the importance of structure in behavior.
Accordingly, the role of the amygdala in ethanol CPP expression has also been addressed. Like
lesions made before conditioning, the bilateral electrolytic lesion of the amygdala made before
the test phase blocked ethanol place preference expression [109]. In addition, when bilaterally
infused into the amygdala, the D1- and D2-like DA receptor agonist flupenthixol blocked
ethanol CPP expression [116]. Together, these results illustrate the role of the amygdala in
ethanol-seeking behavior and indicate the importance of dopaminergic input to this structure
for ethanol CPP expression.
The BNST also has a role in modulating the expression of ethanol reward. Exposure to ethanol
causes changes in glutamate synaptic plasticity [117], increases extracellular DA levels in the
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BNST [118], and activates BNST cells [119]. In particular, the inhibition of the BNST during
CPP expression using electrolytic lesions, coinfusion of GABAA and GABAB receptor agonists
muscimol and baclofen, and activation of inhibitory DREADDs (hM4Di-DREADD) lead to a
loss or reduction of the expression of ethanol CPP. All of these studies suggest the importance
of the BNST to ethanol seeking.
Finally, ACC involvement in expression was assessed by bilaterally infusing the nonspecific
opioid receptor antagonist methylnaloxonium into the ACC before the ethanol CPP test [120].
The intra-ACC infusion of methylnaloxonium disrupted ethanol place preference expression,
reducing its magnitude at the lowest dose and abolishing it at the highest dose. Hence, the
ACC appears to modulate ethanol CPP expression through an opioidergic mechanism.
In summary, findings from expression studies have demonstrated that the VTA, NAc,
amygdala, BNST, and ACC are all structures involved in ethanol place preference expression.
Infusion of a mixed opioid receptor antagonist into VTA and ACC but not NAc interfered with
ethanol CPP expression. Similarly, lesions and mixed DA receptor antagonism disrupted
expression when targeted to the amygdala and not NAc. Involvement of the NAc in ethanol
CPP expression appeared to be confined to activity NMDA receptors only, suggesting that a
more explicit neurochemical mechanism underlies its involvement in ethanol place preference
expression.
5.2.3. Extinction and reinstatement
Unlike the acquisition and expression of ethanol CPP, the neural correlates of extinction of
ethanol CPP is relatively understudied. The only region consistently studied for its role in
ethanol CPP is the mPFC.
The mPFC is known to be involved in the acquisition and extinction of Pavlovian conditioned
fear and drug memories [121]; thus, it is not surprising that disruption of its activity impairs
the extinction of ethanol CPP. Several studies found that lesions or inhibition of the mPFC, but
not the ACC, following acquisition blocks the extinction of CPP [122, 123]. These studies
suggest the importance of this mPFC in the formation of inhibitory ethanol seeking memories.
Additionally, one study links the NAc core with extinction of ethanol seeking. Lesions of the
NAc core were found to have no effect on the expression of ethanol CPP but caused a rapid
loss of responding during extinction [109], which suggest that the NAc core is associated with
inhibitory ethanol memory, but further research will be needed to confirm the role of the NAc
in extinction.
Like extinction, the brain regions involved in the reinstatement of ethanol CPP are not well
studied, but there are several studies that implicate particular brain regions. One such study
found an increase in c-Fos activity in the BLA of rats following cued reinstatement of ethanol
seeking in a discriminative stimulus operant paradigm [75]. Although this is not a direct proof
of the necessity of the BLA in ethanol seeking in CPP, another study found that the direct
manipulation of the BLA alters cued reinstatement of cocaine seeking [59]. Together, these
studies suggest the importance of the BLA in ethanol reinstatement and likely in the reinstate‐
ment of ethanol CPP. Other regions, such as the VTA, amygdala, and BNST, are likely involved
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in the extinction and reinstatement of ethanol CPP, as they are important for the extinction
and reinstatement of CPP of other addictive substances. Investigating the involvement of these
regions in extinction and reinstatement of ethanol CPP will be an important step for under‐
standing the circuitry of relapse.
5.3. Summary
In summary, these studies show the importance of several brain regions heavily implicated in
drug reward to ethanol seeking as well. Most of these studies evaluated the structures situated
downstream the VTA that have been implicated in drug seeking based on their efferent
dopaminergic input. In addition to these studies demonstrating that downstream sites are
involved, findings from Bechtholt and Cunningham [115] further illustrate the importance of
the VTA in ethanol-seeking behavior. As opioid receptors are situated presynaptically on local
GABAergic inputs to DA cells, the authors hypothesized that methylnaloxonium disinhibited
VTA GABAergic interneurons. This likely inhibited VTA DA activity, thereby reducing
ethanol place preference expression. Conversely, baclofen presumably reduced CPP by acting
directly on VTA DA cells, as they express GABAB receptors. Thus, the VTA is a critical structure
for drug and, specifically, ethanol cue associations. Although these findings and proposed
mechanisms underscore the importance of VTA DA in ethanol CPP expression, they provide
little information on the inputs to the VTA that modulate DA cell activity. Thus, the origins
and neurochemical sources of VTA DA cell innervation involved in ethanol-seeking behavior
remain unknown. Accordingly, the next section discusses the involvement of VTA input in
reward and identifies several inputs that may be of importance and deserve further study for
their role in ethanol CPP.
5.4. Inputs to the VTA
Excitatory (glutamatergic) afferents of the VTA arise from virtually all structures to which this
region projects, with the exception of the NAc and lateral septum (LS), which provide strong
GABAergic inputs [124]. This suggests that there is a broad network of excitatory reciprocal
projections to and from the VTA, with much of the glutamatergic input to VTA neurons arising
from subcortical regions that include but are not limited to amygdala, mesopontine nuclei,
lateral habenula, and hypothalamus [125]. Although this reciprocal flow of neurotransmission
is also found between the VTA and cortex, the PFC serves as the only cortical source of
glutamate to the VTA [126]. Importantly, these glutamatergic afferents play a critical role in
regulating VTA neuron firing. Specifically, glutamatergic input to the VTA appears to be
critical for behaviorally relevant burst firing of VTA DA neurons [127]. The resulting phasic
release of DA from the VTA is intimately associated with goal-directed behaviors and drug
reward [128].
In addition to the contemporary methods described earlier, recent advances in immunohisto‐
logical techniques have facilitated a more precise mapping of afferent and efferent projections
of the VTA. As a result, an updated view on the role of broad neural circuit activity (including
that of the VTA) in relation to behavior has been formed. In this current view, the net result of
cell-specific projections onto cell-specific targets is accounted for and the subsequent plotting
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of these circuits suggests a complex topographical map. This map indicates the existence of an
intricate network of connectivity designed to tightly regulate the activity of neuronal ensem‐
bles, which in turn orchestrate complex and divergent behaviors, even from within the same
circuits. In the VTA specifically, not all inputs are alike in their behavioral consequences. Here,
DA activity is governed by a complex network of cell-type-specific neuron-to-neuron connec‐
tions, the net effect of which can result in vastly different motivational states [129, 130].
Several lines of evidence suggest the importance of monosynaptic inputs to VTA DA neurons
(one-step inputs) in governing motivational behaviors. For example, investigation of the
laterodorsal tegmental (LDT) nucleus has revealed that 80% of its glutamatergic afferents
synapse onto VTA DA neurons directly [131]. The importance of these glutamatergic inputs
have been corroborated through electrophysiological analysis, which has shown that this
region is essential to VTA DA cell burst firing [132]. Moreover, in vivo stimulation of LDT
glutamate afferents has been reported to selectively terminate on and stimulate a distinct
population of VTA DA neurons, which thereby generate reward [130].
The BNST is another region upstream the VTA that has been identified as critically involved
in regulating the activity of DA cell activity [133–135]. Specifically, the BNST positively
modulates VTA DA activity putatively through two primary and distinct mechanisms: (1) a
direct glutamate projection to VTA DA and (2) a direct GABA projection to VTA GABA [129,
135–137]. Of note, more recent evidence derived from studies using more advanced and
selective tools suggests that a BNST GABA input to VTA GABA is the predominant source of
the modulation of the BNST of the VTA [129]. Of relevance, behavior in rodents has demon‐
strated that the BNST underlies cue-elicited drug seeking. For example, transient inactivation
of the BNST has been shown to prevent cue-induced reinstatement of cocaine seeking [138].
Direct projections from BNST to VTA appear to be important for cocaine-related behaviors.
For example, disconnection of the BNST-VTA pathway has been shown to reduce expression
of cocaine CPP [62], but the role of that projection in ethanol seeking still remains unknown
and further study of this projection and other VTA inputs will advance our understanding of
the larger neural network driving ethanol seeking.
6. Conclusion
Alcohol is a widely used legal intoxicant that produces a huge financial toll ($223.5 billion in
2006 alone) on the United States (Centers for Disease Control and Prevention, 2014) due to the
workplace, healthcare, legal, and criminal consequences of excessive consumption of alcohol.
Despite the prevalent societal knowledge of the detriment of excessive alcohol use, AUDs
continue to be a common disorder that is difficult to treat. The primary challenge of providing
lasting treatments for AUDs is the high propensity for those with AUDs to relapse into alcohol
use. Relapse is often caused when a cue associated with alcohol (i.e., a bar, alcohol advertise‐
ment) or alcohol itself is presented to a person with an AUD. This cue recalls the associative
effects of ethanol and induces a craving and an internal drive to seek and consume alcohol.
Thus, it is critical to understand how alcohol cue associations are formed and maintained
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despite receiving treatment for alcohol abuse. This chapter has outlined the animal models
that are being used by preclinical researchers to better understand the formation, expression,
extinction, and reinstatement (relapse) of alcohol cue associations that promote ethanol
seeking and has summarized each of their advantages and disadvantages. Of particular use is
the CPP paradigm. CPP allows the experimenter to separate distinct phases of acquiring,
expressing, extinguishing, and reexpressing conditioned ethanol seeking and thus can easily
study the neural mechanisms involved in each. This chapter also presented the classical and
contemporary tools that can be used separately and in conjunction to probe the exact neural
structures and circuitry involved in alcohol cues and seeking. Although classical tools have
given us the greatest insight into the neurobiology of ethanol seeking thus far, contemporary
tools have been and will allow for a much clearer and specific understanding of the structures
involved in animal models of alcohol seeking. Finally, this chapter presented evidence from
ethanol self-administration and ethanol CPP studies of the modulation of ethanol seeking by
the mesolimbic structures (VTA, NAc), the limbic system (amygdala, BNST, ACC), and cortical
structures (mPFC). Of particular importance is the VTA that sends vast dopaminergic input
to many of these structures. The challenge of future research is to identify more structures
critical for the acquisition and expression, and especially the extinction and reinstatement, of
ethanol CPP and the inputs of the VTA that modulate dopaminergic tone and thus ethanol-
seeking behavior (such as the BNST-VTA projection). A better understanding of the whole
circuit driving every aspect of ethanol seeking will improve our knowledge of AUDs and
treatment options.
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